Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Account Payables (2023 - 2025)

Upstream Bio has reported Change in Account Payables over the past 3 years, most recently at -$1.2 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$1.2 million for Q4 2025, down 40.76% from a year ago — trailing twelve months through Dec 2025 was -$1.3 million (down 163.51% YoY), and the annual figure for FY2025 was -$1.3 million, down 163.51%.
  • Change in Account Payables for Q4 2025 was -$1.2 million at Upstream Bio, down from $1.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for UPB hit a ceiling of $3.7 million in Q2 2024 and a floor of -$2.2 million in Q2 2025.
  • Median Change in Account Payables over the past 3 years was -$174000.0 (2024), compared with a mean of $277000.0.
  • Peak annual rise in Change in Account Payables hit 905.17% in 2025, while the deepest fall reached 158.93% in 2025.
  • Upstream Bio's Change in Account Payables stood at $1.8 million in 2023, then crashed by 149.57% to -$871000.0 in 2024, then tumbled by 40.76% to -$1.2 million in 2025.
  • The last three reported values for Change in Account Payables were -$1.2 million (Q4 2025), $1.4 million (Q3 2025), and -$2.2 million (Q2 2025) per Business Quant data.